Plasmapheresis Techniques During Cardiac Surgery

Plasmapheresis is an aggressive autologous blood conservation method utilized in cardiac surgery to reduce patient exposure to homologous blood transfusion. Presently the three perioperative techniques which have been used clinically incorporate varying methodology in producing platelet rich plasma (PRP). However, no prospective randomized study has been made to concurrently examine the benefits of individual devices. Fifty-two consenting adult cardiac patients who met selection criteria were randomly assigned to one of three plasmapheresis devices: Plasma Saver (PS), Cell Saver (CS), and Autotrans 1000 (AT 1000). Following induction of anesthesia, 20% of each patient's estimated plasma volume was removed, stored and then reinfused following the reversal of heparin with protamine. One hundred and twenty-two parameters were measured for each patient. These included anthropomorphic, operative, cardiopulmonary bypass, and postoperative follow-up parameters. Indices of hemostasis were measured which included coagulation screens and thrombelastographic data. There were no differences between groups in all preoperative parameters including the volume of PRP removed. Fibrinogen levels in the PRP were 213.9 +/- 63, 219.4+/-73, and 188.9+/- 69mg/dl in groups PS,CS, and AT 1000 (p=NS), while platelet counts were 178.4 +/- 73, 121.6 +/- 85, and 210.6 +/- 77 109/L, respectively (p<.05 CS vs. AT). There were no differences in chest tube drainage, time on ventilator, or length of ICU stay between groups. However, patients in PS group had significantly lower discharge platelet counts than groups CS and AT 1000. Total homologous blood exposure rate (donor blood exposure per patient) was 8.2 units in group PS, 4.5 in CS, and 5.4 in AT 1000, (p=NS). The currently available techniques for perioperative PRP production differ in both methodology and platelet yield, although the difference did not result in significantly different patient postoperative outcome indices.

[1]  C. Wong,et al.  COMPARISON OF ACT AND TEG IN PATIENTS RECEIVING AUTOLOGOUS PLATELET-RICH-PLASMA DURING CARDIAC SURGERY , 1991 .

[2]  P. Page Perioperative autotransfusion and its correlation to hemostasis and coagulopathies. , 1991, The journal of extra-corporeal technology.

[3]  P. Page Platelet Rich Plasma (PRP) Sequestration Why, When, How? , 1990, The Journal of ExtraCorporeal Technology.

[4]  J. Jones,et al.  Effects of intraoperative plasmapheresis on blood loss in cardiac surgery. , 1990, The Annals of thoracic surgery.

[5]  G. Hempelmann,et al.  Preoperative plasmapheresis in patients undergoing cardiac surgery procedures. , 1990, Anesthesiology.

[6]  R. Mammana,et al.  Determinants of homologous blood usage utilizing autologous platelet-rich plasma in cardiac operations. , 1989, The Annals of thoracic surgery.

[7]  B. Polk,et al.  Transmission of Retroviruses by Transfusion of Screened Blood in Patients Undergoing Cardiac Surgery , 1989, The New England journal of medicine.

[8]  R. Mammana,et al.  Autologous platelet-rich plasma in cardiac surgery: effect on intraoperative and postoperative transfusion requirements. , 1988, The Annals of thoracic surgery.

[9]  J. Ward,et al.  Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody. , 1988, The New England journal of medicine.

[10]  M. Valbonesi,et al.  A new technique for hemodilution, preparation of autologous platelet-rich plasma and intraoperative blood salvage in cardiac surgery , 1987, The International journal of artificial organs.

[11]  L. Harker Bleeding after cardiopulmonary bypass. , 1986, The New England journal of medicine.

[12]  D. B. Williams,et al.  The effect of prostacyclin infusion on platelet hemostatic function in patients undergoing cardiopulmonary bypass. , 1984, The Journal of thoracic and cardiovascular surgery.

[13]  M. Sobel,et al.  Preservation of platelet function and number by prostacyclin during cardiopulmonary bypass. , 1981, The Journal of thoracic and cardiovascular surgery.

[14]  E. Hessel,et al.  Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release. , 1980, Blood.

[15]  Standards for blood banks and transfusion services. , 1977, QRB. Quality review bulletin.

[16]  H. Gralnick,et al.  Heterogeneity of human whole blood platelet subpopulations. I. Relationship between buoyant density, cell volume, and ultrastructure. , 1977, Blood.

[17]  S. Itscoitz,et al.  Evidence that the spleen retains the youngest and hemostatically most effective platelets. , 1968, Transactions of the Association of American Physicians.